Antibiotic resistance of bacteria involved in urinary infections in Brazil: A cross-sectional and retrospective study

International Journal of Environmental Research and Public Health

Volumn 13, Issue 9, 2016, Pages

  Rodrigues, Wellington Francisco ^a,b,c   Miguel, Camila Botelho ^a   Nogueira, Ana Paula Oliveira ^b   Ueira Vieira, Carlos ^b   Paulino, Tony De Paiva ^a   Soares, Siomar De Castro ^a   De Resende, Elisabete Aparecida Mantovani Rodrigues ^a   Lazo Chica, Javier Emilio ^a   Araújo, Marcelo Costa ^a   Oliveira, Carlo José ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^c Morgana Potrich College   (Brazil)

Author keywords

Antibiotics; Bacterial resistance; Escherichia coli; Urinary infection

Indexed keywords

CEFALOTIN; CIPROFLOXACIN; NITROFURANTOIN; NORFLOXACIN; SULTAMICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; SULBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIAL DISEASE; COLIFORM BACTERIUM; DISEASE TREATMENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM IDENTIFICATION; BRAZIL; CROSS-SECTIONAL STUDY; DRUG COST; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; NONHUMAN; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SYMPTOM; URINARY TRACT INFECTION; DRUG EFFECTS; EPIDEMIOLOGY; ESCHERICHIA COLI INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

BRAZIL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BRAZIL; CIPROFLOXACIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NITROFURANTOIN; RETROSPECTIVE STUDIES; SULBACTAM; URINARY TRACT INFECTIONS;

EID: 84989344985     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph13090918     Document Type: Article

References (29)

1. Dalbosco, V., Srougi, M., Dall’Ogilo, M. Infecções do trato urinário. Rev. Bras. Med. 2003, 60, 320-322.
2. Zhanel, G.G., Hisanaga, T.L., Laing, N.M., DeCorby, M.R., Nichol, K.A., Palatnik, L.P., Johnson, J., Noreddin, A., Harding, G.K., Nicolle, L.E. et al. Antibiotic resistance in outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int. J. Antimicrob. Agents 2005, 26, 380-388. [CrossRef] [PubMed]
3. Llor, C., Bjerrum, L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther. Adv. Drug Saf. 2014, 5, 229-241. [CrossRef] [PubMed]
4. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K., Wertheim, H.F., Sumpradit, N., Vlieghe, E., Hara, G.L., Gould, I.M., Goossens, H., et al. Antibiotic resistance—The need for global solutions. Lancet Infect. Dis. 2013, 13, 1057-1098. [CrossRef]
5. World Health Organization. Tuberculosis. Saudi Med. J. 2013, 34, 1205-1207.
6. Cherkaoui, A., Emonet, S., Renzi, G., Riat, A., Greub, G., Schrenzel, J. ESBL and carbapenemases in Enterobacteriaceae. Rev. Med. Suisse 2014, 10, 2142-2148. [PubMed]
7. Trang, N.H.T., Nga, T.V.T., Campbell, J.I., Hiep, N.T., Farrar, J., Baker, S., Duy, P.T. The characterization of ESBL genes in Escherichia coli and Klebsiella pneumoniae causing nosocomial infections in Vietnam. J. Infect. Dev. Ctries. 2013, 7, 922-928. [CrossRef] [PubMed]
8. Coque, T., Baquero, F., Canton, R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eur. Surveill. 2008, 13, 5437-5453.
9. Higgins, C.F. Multiple molecular mechanisms for multidrug resistance transporters. Nature 2007, 446, 749-757. [CrossRef] [PubMed]
10. Krizova, L., Nemec, A. A 63 kb genomic resistance island found in a multidrug-resistant Acinetobacter baumannii isolate of European clone I from 1977. J. Antimicrob. Chemother. 2010, 65, 1915-1918. [CrossRef] [PubMed]
11. Mittal, S., Sharma, M., Chaudhary, U. Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog. Glob. Health 2015, 109, 26-29. [CrossRef] [PubMed]
12. Okeke, I.N., Lamikanra, A., Edelman, R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg. Infect. Dis. 1999, 5, 18. [CrossRef] [PubMed]
13. Simoens, S. Factors affecting the cost effectiveness of antibiotics. Chemother. Res. Pract. 2011, 2011. [CrossRef] [PubMed]
14. Barriere, S.L. Clinical, economic and societal impact of antibiotic resistance. Expert Opin. Pharmacother. 2015, 16, 151-153. [CrossRef] [PubMed]
15. CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard—Twelfth Edition, Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2015.
16. Arango, H.G. Bioestatística teórica e computacional. In Bioestatística Teórica e Computacional, Guanabara Koogan: Rio de Janeiro, Brazil, 2001.
17. Allocati, N., Masulli, M., Alexeyev, M.F., Di Ilio, C. Escherichia coli in Europe: An overview. Int. J. Environ. Res. Publ. Health 2013, 10, 6235-6254. [CrossRef] [PubMed]
18. Linhares, I., Raposo, T., Rodrigues, A., Almeida, A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: A ten-year surveillance study (2000-2009). BMC Infect. Dis. 2013, 13, 19. [CrossRef] [PubMed]
19. Grigoryan, L., Trautner, B.W., Gupta, K. Diagnosis and management of urinary tract infections in the outpatient setting: A review. JAMA 2014, 312, 1677-1684. [CrossRef] [PubMed]
20. Asakura, T., Ikeda, M., Nakamura, A., Kodera, S. Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Int. J. Infect. Dis. 2014, 29, 91-95. [CrossRef] [PubMed]
21. Seija, V., Frantchez, V., Ventura, V., Pintos, M., González, M. Factores asociados al desarrollo de infección urinaria de origen comunitario causada por Escherichia coli resistente a fluoroquinolonas. Rev. Chilena Infectol. 2014, 31, 400-405. [PubMed]
22. Ironmonger, D., Edeghere, O., Bains, A., Loy, R., Woodford, N., Hawkey, P.M. Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years. J. Antimicrob. Chemother. 2015. [CrossRef] [PubMed]
23. Chin, T.L., MacGowan, A.P., Bowker, K.E., Elder, F., Beck, C.R., McNulty, C. Prevalence of antibiotic resistance in Escherichia coli isolated from urine samples routinely referred by general practitioners in a large urban centre in south-west England. J. Antimicrob. Chemother. 2015, 70, 2167-2169. [CrossRef] [PubMed]
24. Hooton, T.M., Besser, R., Foxman, B., Fritsche, T.R., Nicolle, L.E. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: A proposed approach to empirical therapy. Clin. Infect. Dis. 2004, 39, 75-80. [CrossRef] [PubMed]
25. Gupta, K., Hooton, T.M., Naber, K.G., Wullt, B., Colgan, R., Miller, L.G., Moran, G.J., Nicolle, L.E., Raz, R., Schaeffer, A.J., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 2011, 52, e103-e120. [CrossRef] [PubMed]
26. Rattanaumpawan, P. Risk Factors for and Impact of Ambulatory Urinary Tract Infections Caused by High MIC-Fluoroquinolone Susceptible E. coli inWomen. Ph.D. Dissertation, University of Pennsylvania, Philadelphia, PA, USA, 2013.
27. Evans, R.S., Larsen, R.A., Burke, J.P., Gardner, R.M., Meier, F.A., Jacobson, J.A., Conti, M.T., Jacobson, J.T., Hulse, R.K. Computer surveillance of hospital-acquired infections and antibiotic use. JAMA 1986, 256, 1007-1011. [CrossRef] [PubMed]
28. Tängdén, T., Giske, C.G. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: Clinical perspectives on detection, treatment and infection control. J. Intern. Med. 2015, 277, 501-512. [CrossRef] [PubMed]
29. Zowawi, H.M., Harris, P.N., Roberts, M.J., Tambyah, P.A., Schembri, M.A., Pezzani, M.D., Williamson, D.A., Paterson, D.L. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat. Rev. Urol. 2015, 12, 570-584. [CrossRef] [PubMed]